Business
CSL confirms UQ vaccine production, trials set for December – Sydney Morning Herald
The blood plasma giant has sealed its deal with the Australian government, confirming it is ready to produce an Australian COVID-19 vaccine candidate if trials …
Blood plasma giant CSL has confirmed the deal with the Australian government to produce the University of Queensland’s COVID-19 vaccine has been sealed, with the next stage of trials planned to start in December.
The $132 billion biotech told investors on Thursday morning it had signed off on the final agreement to produce 51 million doses of the University of Queensland (UQ) vaccine , known as V451, if it is successful. It said first participants in the phase 2b/3 trials of the product would b…
-
Noosa News8 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News9 hours agoMotorcyclist dies in crash with truck
-
Noosa News24 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General23 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate